Literature DB >> 20964956

ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.

Fidel Vila-Rodriguez1, William G Honer, Sheila M Innis, Cheryl L Wellington, Clare L Beasley.   

Abstract

BACKGROUND: Apolipoprotein E (apoE) and cholesterol play a critical role in synapse and myelin maintenance and integrity and are thus appealing candidates in the pathogenesis of schizophrenia and bipolar disorder. To explore the role of these 2 molecules, we quantified cholesterol and apoE levels in prefrontal grey and white matter in patients with schizophrenia, bipolar disorder and healthy controls. Furthermore, we investigated the relations between apoE and cholesterol levels and the APOE genotype.
METHODS: We obtained dorsolateral prefrontal grey and white matter from the Stanley Medical Research Institute Brain Collection (schizophrenia n = 35, bipolar disorder n = 35 and controls n = 35). Cholesterol levels were quantified using high-pressure liquid chromatography, whereas apoE was measured by enzyme-linked immunosorbent assay.
RESULTS: We found no significant differences in cholesterol or apoE levels among the groups. ApoE levels were higher in grey matter than in white matter in all groups; conversely, levels of cholesterol were higher in white matter than in grey matter. We observed a significant inverse correlation between apoE and cholesterol levels in both grey and white matter. Furthermore, in grey matter, apoE levels were significantly higher in APOE ε2 carriers compared with APOE ε3 or APOE ε4 carriers, with cholesterol levels following the opposite trend. LIMITATIONS: LIMITATIONS of our study include our inability to control for potential confounding variables and the small numbers of APOE ε2 and ε4 carriers in each group.
CONCLUSION: Although large amounts of cholesterol are present in white matter, apoE expression is limited. The APOE genotype may play a role in the regulation of both cholesterol and apoE levels in grey matter. The impact of APOE polymorphisms on lipid homeostasis in people with psychiatric disorders warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20964956      PMCID: PMC3004975          DOI: 10.1503/jpn.090116

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  53 in total

1.  Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts.

Authors:  M Atmaca; M Kuloglu; E Tezcan; B Ustundag
Journal:  Acta Psychiatr Scand       Date:  2003-09       Impact factor: 6.392

2.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

3.  Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.

Authors:  J A Morrow; M L Segall; S Lund-Katz; M C Phillips; M Knapp; B Rupp; K H Weisgraber
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

4.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?

Authors:  R M Corbo; R Scacchi
Journal:  Ann Hum Genet       Date:  1999-07       Impact factor: 1.670

Review 5.  Cholesterol metabolism in the brain.

Authors:  J M Dietschy; S D Turley
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

6.  Cholesterol content in brains of suicide completers.

Authors:  Aleksandra Lalovic; Emile Levy; Giamal Luheshi; Lilian Canetti; Emilie Grenier; Adolfo Sequeira; Gustavo Turecki
Journal:  Int J Neuropsychopharmacol       Date:  2006-05-17       Impact factor: 5.176

7.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.

Authors:  G Rosoklija; G Toomayan; S P Ellis; J Keilp; J J Mann; N Latov; A P Hays; A J Dwork
Journal:  Arch Gen Psychiatry       Date:  2000-04

8.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

9.  Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.

Authors:  J T-J Huang; L Wang; S Prabakaran; M Wengenroth; H E Lockstone; D Koethe; C W Gerth; S Gross; D Schreiber; K Lilley; M Wayland; D Oxley; F M Leweke; S Bahn
Journal:  Mol Psychiatry       Date:  2007-10-16       Impact factor: 15.992

10.  Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.

Authors:  David R Riddell; Hua Zhou; Kevin Atchison; Helen K Warwick; Peter J Atkinson; Julius Jefferson; Lin Xu; Suzan Aschmies; Yolanda Kirksey; Yun Hu; Erik Wagner; Adrienne Parratt; Jane Xu; Zhuting Li; Margaret M Zaleska; J Steve Jacobsen; Menelas N Pangalos; Peter H Reinhart
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

View more
  7 in total

1.  Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.

Authors:  Khaled Al Awam; Ida Sibylle Haußleiter; Ed Dudley; Rossen Donev; Martin Brüne; Georg Juckel; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2014-05-01       Impact factor: 3.575

2.  Multiblock discriminant analysis for integrative genomic study.

Authors:  Mingon Kang; Dong-Chul Kim; Chunyu Liu; Jean Gao
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 3.  Potential biomarkers in psychiatry: focus on the cholesterol system.

Authors:  Alisa G Woods; Izabela Sokolowska; Regina Taurines; Manfred Gerlach; Edward Dudley; Johannes Thome; Costel C Darie
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

4.  Association between APOE polymorphisms and lipid profile in Mexican Amerindian population.

Authors:  José J Martínez-Magaña; Alma D Genis-Mendoza; Carlos A Tovilla-Zarate; Thelma B González-Castro; Isela Esther Juárez-Rojop; Yazmín Hernández-Díaz; Angélica G Martinez-Hernandez; Humberto Garcia-Ortíz; Lorena Orozco; María L López-Narvaez; Humberto Nicolini
Journal:  Mol Genet Genomic Med       Date:  2019-09-26       Impact factor: 2.183

5.  Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder.

Authors:  Christian Knöchel; Jonathan Kniep; Jason D Cooper; Michael Stäblein; Sofia Wenzler; Jan Sarlon; David Prvulovic; David E J Linden; Sabine Bahn; Pawel Stocki; Sureyya Ozcan; Gilberto Alves; Andre F Carvalho; Andreas Reif; Viola Oertel-Knöchel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-22       Impact factor: 5.270

6.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

7.  Lipidomic signatures from physically frail and robust older adults at hospital admission.

Authors:  Robinson Ramírez-Vélez; Nicolás Martínez-Velilla; María Correa-Rodríguez; Mikel L Sáez de Asteasu; Fabricio Zambom-Ferraresi; Sara Palomino-Echeverria; Antonio García-Hermoso; Mikel Izquierdo
Journal:  Geroscience       Date:  2022-02-04       Impact factor: 7.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.